Speaker Details

Laura K. Ferris, MD, PhD, FAAD

Laura K. Ferris, MD, PhD, FAAD

SESSIONS

F011 What's New in the Management of Advanced Skin Cancer
Mar 27, 2026 1:00 PM - 3:00 PM Bluebird 2B
F087 Melanoma in Situ: Ongoing Controversies and New Insights
Mar 30, 2026 1:00 PM - 3:00 PM Mile High 2A

DISCLOSURES

AbbVie – Consultant(Honoraria), Investigator(Other Financial Benefit); Almirall – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Other Financial Benefit); Arcutis, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Other Financial Benefit), Speaker(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria); Cara Therapeutics – Consultant(Honoraria); Castle Biosciences, Inc – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Janssen Research & Development, LLC – Investigator(Other Financial Benefit); Novartis – Investigator(Other Financial Benefit); Pfizer Inc. – Data Safety Monitoring Board(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Other Financial Benefit); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Investigator(Grants/Research Funding);